Plasma therapy in atypical haemolytic uremic syndrome: lessons from a family with a factor H mutation

Whilst randomised control trials are undoubtedly the best way to demonstrate whether plasma exchange or infusion alone is the best first-line treatment for patients with atypical haemolytic uremic syndrome (aHUS), individual case reports can provide valuable information. To that effect, we have had...

Descripción completa

Detalles Bibliográficos
Autores principales: Davin, Jean Claude, Strain, Lisa, Goodship, Tim H. J.
Formato: Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2008
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2459233/
https://www.ncbi.nlm.nih.gov/pubmed/18483746
http://dx.doi.org/10.1007/s00467-008-0833-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2459233/
https://www.ncbi.nlm.nih.gov/pubmed/18483746
http://dx.doi.org/10.1007/s00467-008-0833-y

Ejemplares similares